IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aquilo Capital Management, LLC

Q1 2021 Holdings

Filed 2021-05-17 | 17 holdings | $33.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arrowhead Pharmaceuticals in(ARWR)COM04280A100$27.1M407,92681.0%
Argenx SE(ARGX)SPONSORED ADR04016X101$5.8M21,20017.5%
Spdr S&P 500 ETF TR(SPY)PutUNIT78462F103$118.9K300,0000.4%
Spdr S&P Biotech ETF TR(XBI)PutUNIT78464A870$67.8K500,0000.2%
Spero Therapeutics Inc(SPRO)COM84833T103$56.4K3,829,2090.2%
Dicerna Pharmaceuticals Inc(DRNAUSD)COM253031108$43.6K1,705,3920.1%
Blueprint Medicines Corp(2L9)COM09627Y109$41.1K423,0120.1%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$32.7K1,124,2370.1%
Harpoon Therapeutics IncCOM41358P106$32.5K1,554,1990.1%
Uniqure NV(QURE)SHSN90064101$32.2K955,4240.1%
Magenta Therapeutics IncCOM55910K108$29.6K2,502,2100.1%
Regenxbio Inc(RGNX)COM75901B107$19.1K559,4440.1%
4D Molecular Therapeutics in(FDMT)COM35104E100$13.1K300,8860.0%
Amryt Pharma PLCSPONSORED ADS03217L106$11.1K800,0000.0%
Pieris Pharmaceuticals IncCOM720795103$9.4K3,675,5300.0%
Galapagos NV(GLPG)SPON ADR36315X101$9.0K116,7230.0%
Genmab A/S(GMAB)SPONSORED ADS372303206$3.9K120,0000.0%